Successful treatment of paediatric refractory Hodgkin lymphoma with immunotherapy - A case report and literature review.

Although it remains to be proven in randomised trials, anti-PD-1 therapy may provide higher complete response rates than traditional chemotherapy. Anti-PD-1 therapy has the potential to increase the chance of cure while decreasing the risk of late effects from chemotherapy and radiotherapy.